Liver injury in remdesivir-treated COVID-19 patients-Reference-Cited by-同舟云学术

Liver injury in remdesivir-treated COVID-19 patients

Published:2020-07-28 Issue:5 Volume:14 Page:881-883
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Zampino Rosa,Mele Ferruccio,Florio Letizia Lucia,Bertolino Lorenzo,Andini Roberto,Galdo Maria,De Rosa Rosanna,Corcione Antonio,Durante-Mangoni Emanuele^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-020-10077-3.pdf

Reference5 articles.

1. Zhao D, Yao F, Wang L, Zheng L, Gao Y, Ye J, et al. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa247(pii:ciaa247).

2. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020. https://doi.org/10.1111/liv.14435.

3. Chan KW, Wong VT, Tang SCW. COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-western medicine for the management of 2019 novel coronavirus disease. Am J Chin Med. 2020;13:1–26. https://doi.org/10.1142/S0192415X20500378.

4. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate use of remdesivir for patients with severe covid-19. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2007016.

5. Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)31022-9.

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between ursodeoxycholic acid use and COVID-19 in individuals with chronic liver disease: a nationwide case-control study in South Korea;Virology Journal;2024-08-27

2. Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients;Frontiers in Pharmacology;2024-07-31

3. COVID-19 therapeutics;Clinical Microbiology Reviews;2024-06-13

4. Effects of Remdesivir on liver enzymes, oxidative stress and Liver histopathology in rats;2024-06-13

5. Mechanistic Understanding of Dexamethasone-Mediated Protection against Remdesivir-Induced Hepatotoxicity;Molecular Pharmacology;2024-05-20